glp 1 agonist drugs mechanism of action Current Insights, Advantages and Challenges Small Molecule Glucagon-like Peptide Receptor Agonists: A Scoping Review GLP-1 receptor agonists (GLP-1RAs): cardiovascular
Description
People who are obese (have a BMI greater than or equal to 30) are clinically eligible for GLP-1 drugs, but employer plans may set additional BMI requirements to cover GLP-1 drug use under obesity
JBMR Plus
This is safe, moderate weight loss that I think most of our patients with obesity require, said lead study author W
Treat any advert for GLP-1 patches with caution , especially if it's being promoted by an influencer on social media or making bold claims about weight loss results
